Tumor lysis syndrome
Showing 1 - 25 of >10,000
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive
Active, not recruiting
- Aggressive B-Cell Non-Hodgkin Lymphoma
- fractionated first dose rituximab
-
Geneva, SwitzerlandUniversity Hospital Geneva
Apr 21, 2023
Leukemia, Lymphoma Trial in Houston (Rasburicase, Allopurinol)
Completed
- Leukemia
- Lymphoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 23, 2020
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,
Recruiting
- Carcinoid Syndrome
- +8 more
- Randomized: 40 mg Paltusotine
- Randomized: 80 mg Paltusotine
-
Newport Beach, California
- +5 more
Jan 3, 2023
PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,
Not yet recruiting
- PTEN Gene Mutation
- +2 more
- Sirolimus
- Placebo
-
Stanford, California
- +2 more
Oct 5, 2023
Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA
Recruiting
- Lynch Syndrome
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
- +2 more
-
Duarte, California
- +3 more
Nov 22, 2022
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition
Recruiting
- Pleuropulmonary Blastoma
- +4 more
-
Bethesda, Maryland
- +1 more
Dec 29, 2022
Extracorporeal Photopheresis in Sezary Syndrome
Recruiting
- Sezary Syndrome
- Extracorporeal photopheresis (ECP)
- Methoxsalen Injection
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Aug 12, 2022
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)
Not yet recruiting
- Relapsed Non-Hodgkin Lymphoma
- +6 more
- (no location specified)
Apr 12, 2023
Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)
Completed
- Neuroendocrine Tumors
- +3 more
- Amino Acid Based Medical Food/Drink
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 2, 2022
Elucidating Genetic Basis of Pleuropulmonary Blastoma Familial
Active, not recruiting
- Pleuropulmonary Blastoma
- +9 more
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 9, 2022
Online Neurobehavioral Evaluation Tool for PTEN Patients
Recruiting
- PTEN Hamartoma Tumor Syndrome
- NET
-
University Heights, OhioJohn Carroll Univeristy
Jan 3, 2023
Renal Autotransplantation; Case Series
Enrolling by invitation
- Renal Vascular Disease
- +5 more
- Pre-Operative Information
- +3 more
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Dec 20, 2022
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
RASopathy, Costello Syndrome, Cardio-Facio-Cutaneous Syndrome Trial in Roma (Molecular characterization of solid tumor in
Recruiting
- RASopathy
- +3 more
- Molecular characterization of solid tumor in RASopathies
-
Roma, ItalyDepartment of Woman and Child Health and Public Health, Fondazio
Feb 27, 2023
PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome Trial in Palo Alto, Boston, Cleveland (RAD001, Placebo)
Completed
- PTEN Gene Mutation
- PTEN Hamartoma Tumor Syndrome
- RAD001
- Placebo
-
Palo Alto, California
- +2 more
Feb 7, 2022
Frequency, Clinical Phenotype and Genetic Analysis of Heritable
Not yet recruiting
- Renal Tumor Histology
- +13 more
- Gene test
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Sep 6, 2022
Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS) Trial in United States (Burosumab)
Completed
- Tumor Induced Osteomalacia (TIO)
- Epidermal Nevus Syndrome (ENS)
- Burosumab
-
Golden, Colorado
- +6 more
Jan 20, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Zanubrutinib Pill
- +2 more
-
New York, New YorkWeill Cornell Medicine/NewYork-Presberteryian Hospital
Dec 6, 2022
Neuroendocrine Tumor, Carcinoid Syndrome Trial in Nashville (Enterade®, Functional Assessment of Chronic Illness Therapy for
Terminated
- Neuroendocrine Tumor
- Carcinoid Syndrome
- Enterade®
- Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0)
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
May 18, 2021
Cancer, Cancer-Related Syndrome, Fatigue Trial in Salamanca (Multimodal Exercise and Functional Rehabilitation Program)
Completed
- Cancer
- +2 more
- Multimodal Exercise and Functional Rehabilitation Program
-
Salamanca, SpainUniversidad de Salamanca
Jul 12, 2022